Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.

Thanks to the alternating single-double nature of the bonds, electrons in these orbitals end up delocalized; the differences between the bonds become a bit irrelevant, and the molecule is best viewed ...